Front Cardiovasc Med. 2021 Oct 14;8:763984. doi: 10.3389/fcvm.2021.763984. eCollection 2021.
Metabolic Profile in Neonatal Pig Hearts.
Frontiers in cardiovascular medicine
Pengsheng Li, Fan Li, Ling Tang, Wenjing Zhang, Yan Jin, Haiwei Gu, Wuqiang Zhu
Affiliations
Affiliations
- Department of Cardiovascular Diseases, Physiology and Biomedical Engineering, Center for Regenerative Medicine, Mayo Clinic Arizona, Scottsdale, AZ, United States.
- Laboratory of Regenerative Medicine in Sports Science, School of Physical Education and Sports Science, South China Normal University, Guangzhou, China.
- College of Health Solutions, Arizona State University, Phoenix, AZ, United States.
- Department of Environmental Health Sciences, Robert Stempel College of Public Health and Social Work, Florida International University, Miami, FL, United States.
- Department of Cellular Biology and Pharmacology, Herbert Wertheim College of Medicine, Center for Translational Science, Florida International University, Port St. Lucie, FL, United States.
PMID: 34722687
PMCID: PMC8551694 DOI: 10.3389/fcvm.2021.763984
Abstract
We evaluated the metabolic profile in pig hearts at postnatal day 1, 3, 7, and 28 (P1, P3, P7, and P28, respectively) using a targeted liquid chromatography tandem mass spectrometry assay. Our data showed that there is a clear separation of the detected metabolites in P1 vs. P28 hearts. Active anabolisms of nucleotide and proteins were observed in P1 hearts when cardiomyocytes retain high cell cycle activity. However, the active posttranslational protein modification, metabolic switch from glucose to fatty acids, and the reduced ratio of collagen to total protein were observed in P28 hearts when cardiomyocytes withdraw from cell cycle.
Copyright © 2021 Li, Li, Tang, Zhang, Jin, Gu and Zhu.
Keywords: heart; metabolism; metabolomics; neonatal; pig
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
- J Am Heart Assoc. 2018 Oct 16;7(20):e010378 - PubMed
- Circ Res. 2018 Jan 5;122(1):88-96 - PubMed
- Am J Physiol. 1997 Aug;273(2 Pt 1):E239-46 - PubMed
- Proc Natl Acad Sci U S A. 2017 Oct 3;114(40):E8372-E8381 - PubMed
- J Am Coll Cardiol. 1994 Apr;23(5):1204-8 - PubMed
- Circulation. 2018 Dec 11;138(24):2809-2816 - PubMed
- Circ Res. 2013 Aug 16;113(5):603-16 - PubMed
- Am J Cardiol. 1997 Aug 4;80(3A):17A-25A - PubMed
- Am J Physiol. 1991 Dec;261(6 Pt 2):H1698-705 - PubMed
- Science. 1965 Oct 15;150(3694):364-6 - PubMed
- Cell Rep. 2020 Sep 1;32(9):108087 - PubMed
- Methods Mol Biol. 2009;466:223-35 - PubMed
- J Am Heart Assoc. 2019 Jun 18;8(12):e012673 - PubMed
- Front Oncol. 2017 Dec 20;7:313 - PubMed
- Am J Physiol. 1994 Jan;266(1 Pt 2):H354-9 - PubMed
- EMBO Rep. 2020 Aug 5;21(8):e49752 - PubMed
- Science. 2011 Feb 25;331(6020):1078-80 - PubMed
- J Cardiovasc Pharmacol. 2010 Aug;56(2):130-40 - PubMed
- Mol Cell Biochem. 1998 Nov;188(1-2):49-56 - PubMed
- J Proteome Res. 2021 Sep 3;20(9):4303-4317 - PubMed
- J Appl Physiol. 1976 Jun;40(6):923-6 - PubMed
- Am J Physiol. 1977 Dec;233(6):H707-10 - PubMed
- Mol Ther Nucleic Acids. 2018 Dec 7;13:133-143 - PubMed
- Nucleic Acids Res. 2015 Feb 27;43(4):2466-85 - PubMed
- Cancer Res. 2018 Aug 15;78(16):4459-4470 - PubMed
Publication Types